Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY Anticipated Dispensing Commencement and Flora Sync LF5 Commercial Launch Summer 2026 ...
Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ ...
NC legislative leaders agree on healthcare, raises, tax cuts. Still uncertain on some spending. Unclear if budget deal could ...
Bank of America Global Healthcare Conference 2026 May 13, 2026 5:20 PM EDTCompany ParticipantsRamy Farid - CEO, President ...
The proposed smart glasses would move identity checks from handheld devices into wearable equipment that agents could use ...
About 70,000 Americans died of drug overdoses last year — about 14% fewer than the previous year, according to preliminary ...
Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?
A Bristol-based biotech firm has made major advances towards developing a vaccine for hantavirus. EnsiliTech, based at ...
The goal of the fund is to enable researchers to make bold leaps rather than incremental advances in the natural sciences and ...
The Pilot Grant Program was established in 2025 to foster new Rutgers-wide collaborations that capitalize on the university’s ...
Startups have developed chips that allow people to control machines with their thoughts. Billionaires are betting these brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results